CN106883233A - The synthetic method of adenine and its derivative - Google Patents

The synthetic method of adenine and its derivative Download PDF

Info

Publication number
CN106883233A
CN106883233A CN201710108136.8A CN201710108136A CN106883233A CN 106883233 A CN106883233 A CN 106883233A CN 201710108136 A CN201710108136 A CN 201710108136A CN 106883233 A CN106883233 A CN 106883233A
Authority
CN
China
Prior art keywords
reaction
adenine
mentioned steps
synthetic method
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710108136.8A
Other languages
Chinese (zh)
Other versions
CN106883233B (en
Inventor
张元元
周安飞
孙永辉
孔繁蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Gao Heng Biological Science And Technology Co Ltd
JIANGSU AGRICULTURAL HORMONE ENGINEERING TECHNOLOGY RESEARCH CENTRE Co Ltd
Original Assignee
Nanjing Gao Heng Biological Science And Technology Co Ltd
JIANGSU AGRICULTURAL HORMONE ENGINEERING TECHNOLOGY RESEARCH CENTRE Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Gao Heng Biological Science And Technology Co Ltd, JIANGSU AGRICULTURAL HORMONE ENGINEERING TECHNOLOGY RESEARCH CENTRE Co Ltd filed Critical Nanjing Gao Heng Biological Science And Technology Co Ltd
Priority to CN201710108136.8A priority Critical patent/CN106883233B/en
Publication of CN106883233A publication Critical patent/CN106883233A/en
Application granted granted Critical
Publication of CN106883233B publication Critical patent/CN106883233B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of adenine and its synthetic method of derivative, it is first to obtain 2 tartronic acid diethylesters by the oxidized reaction of diethyl malonate and dimethyl dioxirane;Then 2 hydroxyl malonamides are obtained through ammonolysis reaction with ammoniacal liquor;Then 5 hydroxy pyrimidines 4,6 are obtained through ring-closure reaction with trimethyl orthoformate(1H,5H)Diketone;Again 4,5,6 trichloropyrimidines are obtained with phosgene through chlorination reaction;Again 4 chlorine 1H pyrazoles [3,4 d] pyrimidines are obtained with amitraz hydrochloride through ring-closure reaction;Finally adenine or derivatives thereof is obtained with ammoniacal liquor or aminated compounds through aminating reaction in the presence of triethyl amine.Synthetic method raw material of the invention is cheap and easy to get, and reaction condition is gentle, course of reaction safety, low to production equipment requirement, and especially environmental pollution is smaller, and yield is higher, so as to be adapted to industrialized production.

Description

The synthetic method of adenine and its derivative
Technical field
The present invention relates to medicine bioengineering chemical field, and in particular to the synthetic method of a kind of adenine and its derivative.
Background technology
Adenine, chemical name is adenine, is the constituent of nucleic acid, is mainly used in participating in organism RNA and DNA synthesizes, and when leucocyte lacks, can promote leucocyte hyperplasia.There is adenine phytokinin to act on, its tablet Or injection can be used for graininess leukopenia etc., it can also be used to prepare the medicine such as biochemical reagents and purine analog derivative, also Can be used for blood storage.
At present, the synthetic method of adenine mainly has three kinds of adenosine method, hypoxanthine method and diethyl malonate method.
The deficiency of adenosine method is:Adenosine price is higher and limited source, causes production cost higher, so as to be not suitable for work The big production of industryization.
Hypoxanthic deficiency is:Hypoxanthine is obtained by inosine cracking, therefore, the same price is higher and source has Limit, same production cost is higher and be not suitable for industrialized production.
Diethyl malonate method has the advantages that raw material is cheap and easy to get relative to adenosine method and hypoxanthine method.But, it is existing The synthetic route of some diethyl malonate methods is first to obtain 4,6- dihydroxy-pyrimidines through amitraz hydrochloride cyclization;Again through nitrification and Chlorination obtains the chloro- 5- nitro-pyrimidines of 4,6- bis-;Then by the chloro- 5- nitro-pyrimidines of 4,6- bis- through ammoniacal liquor ammonification, sodium hydrosulfite reduction with And formic acid cyclization obtain/or obtain adenine through iron powder reducing, formamide cyclization and ammoniacal liquor ammonification.
The deficiency of the method is:Yield is extremely low, and two kinds of adenine are especially prepared by the chloro- 5- nitro-pyrimidines of 4,6- bis- Method yield can produce a large amount of waste liquids less than 50% using POCl3 chlorination and nitrification, cause environmental pollution It is larger, so as to be also not suitable for industrialized production.
The content of the invention
It is an object of the invention to solve the above problems, there is provided a kind of production cost is relatively low, environmental pollution is smaller, yield The synthetic method of adenine that is higher, being adapted to industrialized production and its derivative.
Realizing the technical scheme of above-mentioned purpose of the present invention is:A kind of synthetic method of adenine and its derivative, with Lower step:
1. 2- tartronic acid diethylesters are obtained by the oxidized reaction of diethyl malonate and dimethyl dioxirane;
2. 2- hydroxyl malonamides are obtained through ammonolysis reaction by 2- tartronic acids diethylester and ammoniacal liquor;
3. 5- hydroxy pyrimidines -4,6- is obtained through ring-closure reaction by 2- hydroxyls malonamide and trimethyl orthoformate(1H,5H)- two Ketone;
4. by 5- hydroxy pyrimidines -4,6-(1H,5H)- diketone obtains 4,5,6- trichloropyrimidines with phosgene through chlorination reaction;
5. chloro- 1H- pyrazoles [3,4-d] pyrimidines of 4- are obtained through ring-closure reaction by 4,5,6- trichloropyrimidines and amitraz hydrochloride;
6. by chloro- 1H- pyrazoles [3,4-d] pyrimidines of 4- and ammoniacal liquor or aminated compounds in the presence of triethyl amine through aminating reaction Obtain adenine or derivatives thereof.
Above-mentioned steps oxidation reaction 1. is carried out in the presence of a catalyst;The catalyst is acetate, preferably It is nickel acetate;The consumption of the catalyst is the 0.1%~1% of diethyl malonate weight.
Above-mentioned steps oxidation reaction 1. is carried out in the presence of alcohols solvent;The alcohols solvent is methyl alcohol, second Alcohol, isopropanol or n-butanol, preferably ethanol.
Above-mentioned steps 1. described in the mol ratio of diethyl malonate and the dimethyl dioxirane be 1: 1~1: 3, preferably 1: 1.5.
Above-mentioned steps oxidizing reaction temperature 1. is back flow reaction temperature.
Above-mentioned steps oxidation time 1. is 2~10h, preferably 5h.
Above-mentioned steps 2. described in the mol ratio of 2- tartronic acids diethylester and the ammoniacal liquor be 1: 1~1: 3, preferably 1∶2。
Above-mentioned steps ammonolysis reaction temperature 2. is 50~150 DEG C, preferably 90 DEG C;The ammonolysis reaction time is 1~5h, excellent Elect 3h as.
Above-mentioned steps 3. described in the mol ratio of 2- hydroxyls malonamide and the trimethyl orthoformate be 1: 1~1: 3, it is excellent Elect 1: 1 as.
Above-mentioned steps ring-closure reaction 3. is carried out in the presence of alcohols solvent;The alcohols solvent is methyl alcohol, second Alcohol, isopropanol or n-butanol, preferably ethanol.
Above-mentioned steps ring-closure reaction temperature 3. is room temperature(15~25 DEG C, similarly hereinafter);Reaction time is 12h.
Above-mentioned steps 4. in be passed through phosgene temperature be -5~10 DEG C, preferably 0 DEG C;The time for being passed through phosgene is 1~3h.
Above-mentioned steps chlorination reaction 4. is carried out in the presence of NaOH.
Above-mentioned steps chlorination reaction 4. is carried out in dichloroethane solvent.
Above-mentioned steps 5. described in the mol ratio of 4,5,6- trichloropyrimidines and the amitraz hydrochloride be 1: 1~1: 3, preferably It is 1: 1.
Above-mentioned steps ring-closure reaction 5. is carried out in the presence of alcohols solvent;The alcohols solvent is methyl alcohol, second Alcohol, isopropanol or n-butanol, preferably ethanol.
Above-mentioned steps ring-closure reaction temperature 5. is room temperature;Reaction time is 12h.
Above-mentioned steps 6. described in chloro- 1H- pyrazoles [3,4-d] pyrimidines of 4- and the ammoniacal liquor or aminated compounds mole Than being 1: 1~1: 3, preferably 1: 1.1.
Above-mentioned steps 6. described in the mol ratio of chloro- 1H- pyrazoles [3,4-d] pyrimidines of 4- and the triethylamine be 1: 1~1: 3, preferably 1: 1.2.
Above-mentioned steps aminating reaction 6. is carried out in the presence of alcohols solvent;The alcohols solvent is methyl alcohol, second Alcohol, isopropanol or n-butanol, preferably ethanol.
Above-mentioned steps aminating reaction temperature 6. is back flow reaction temperature.
The above-mentioned steps aminating reaction time 6. is 2~10h, preferably 5h.
The good effect that the present invention has:Synthetic method raw material of the invention is cheap and easy to get, and reaction condition is gentle, reacts Cheng Anquan, low to production equipment requirement, especially environmental pollution is smaller, and yield is higher, so as to be adapted to industrialized production.
Specific embodiment
(Embodiment 1)
The present embodiment is the synthetic method of adenine, and the route of the synthetic method is as follows:
The synthetic method has steps of:
1. by the diethyl malonate of 160g(1mol)It is dissolved in 300mL ethanol, adds the dimethyl dioxirane of 111g (1.5mol)With the nickel acetate of 0.5g, backflow is then heated to, reacts 5h.
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 170g 2- tartronic acid diethylesters, yield is 96.6%.
2. by the 2- tartronic acid diethylesters of 176g(1mol)It is the ammoniacal liquor of 28wt% with 250g, concentration(2mol)Mixing, 90 DEG C are then heated to, 3h is reacted.
After reaction terminates, water is added, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain the 2- hydroxyls third of 115g Diamides, yield is 97.5%.
3. at 0 DEG C, by the trimethyl orthoformate of 106g(1mol)It is dissolved in 200mL ethanol, is slowly added dropwise 100mL containing 118g 2- hydroxyl malonamides(1mol)Ethanol solution, drip off and be heated to 15~25 DEG C, stirring reaction 12h.
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 120g 5- hydroxy pyrimidines -4,6-(1H,5H)- diketone, yield is 93.8%.
4. by the 5- hydroxy pyrimidines -4,6- of 128g(1H,5H)- diketone(1mol)It is dissolved in 200mL dichloroethanes, at 0 DEG C, Phosgene 2h is slowly introducing, has been led to(About 2h)15~25 DEG C are heated to, first stirring reaction 12h adds 100g, concentration for 30wt% Sodium hydroxide solution, continue stirring reaction 3h.
After reaction terminates, water is added, extracted 3 times with dichloroethanes, organic layer is spin-dried for, obtain the 4 of 175g, 5,6- trichlorines Pyrimidine, yield is 95.4%.
5. at 0 DEG C, by the amitraz hydrochloride of 80.5g(1mol)It is dissolved in 200mL ethanol, is slowly added dropwise 100mL and contains The 4,5,6- trichloropyrimidines of 183.5g(1mol)Ethanol solution, drip off and be heated to 15~25 DEG C, stirring reaction 12h.
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 150g Chloro- 1H- pyrazoles [3, the 4-d] pyrimidines of 4-, yield is 97.1%.
6. by chloro- 1H- pyrazoles [3,4-d] pyrimidines of the 4- of 154.5g(1mol)It is dissolved in 200mL ethanol, first adds 122g's Triethylamine(1.2mol), then it is slowly added dropwise the ammoniacal liquor that 138g, concentration are 28wt%(1.1mol), drip off and be heated to backflow, reaction 5h。
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 130g White solid adenine, yield is 96.3%.
(Embodiment 2)
The present embodiment is 6-Furfurylaminopurine(Namely kinetin)Synthetic method, the step of the method and embodiment 1 1.~5. It is identical, difference be step 6.:By chloro- 1H- pyrazoles [3,4-d] pyrimidines of the 4- of 154.5g(1mol)It is dissolved in 200mL ethanol In, first add the triethylamine of 122g(1.2mol), then it is slowly added dropwise the 2- furylamines of 107g(1.1mol), drip off heating To flowing back, 5h is reacted.
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 208g White solid 6-Furfurylaminopurine, yield is 96.7%.
(Embodiment 3)
The present embodiment is oxyenadenine(Namely zeatin)Synthetic method, 1.~5. phase the step of the method is with embodiment 1 Together, difference be step 6.:By chloro- 1H- pyrazoles [3,4-d] pyrimidines of the 4- of 154.5g(1mol)It is dissolved in 200mL ethanol, First add the triethylamine of 122g(1.2mol), then it is slowly added dropwise the 4- amino-2-methyl -2- butenols of 111g(1.1mol), Drip off and be heated to backflow, react 5h.
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 212g Pale powder oxyenadenine, yield is 96.8%.
(Embodiment 4)
The present embodiment is the synthetic method of carbonyl enadenine, the step of the method is with embodiment 1 1.~it is 5. identical, difference exists In step 6.:By chloro- 1H- pyrazoles [3,4-d] pyrimidines of the 4- of 154.5g(1mol)It is dissolved in 200mL ethanol, first adds 122g's Triethylamine(1.2mol), then it is slowly added dropwise the 3- methyl-2-butene acid amides of 103g(1.1mol), drip off and be heated to backflow, instead Answer 5h.
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 210g White powder carbonyl enadenine, yield is 96.8%.
(Embodiment 5)
The present embodiment is the synthetic method of isopentenyl gland purine, the step of the method is with embodiment 1 1.~it is 5. identical, difference Place be step 6.:By chloro- 1H- pyrazoles [3,4-d] pyrimidines of the 4- of 154.5g(1mol)It is dissolved in 200mL ethanol, first adds The triethylamine of 122g(1.2mol), then it is slowly added dropwise the 4- amino-2-methyl -2- butylene of 93g(1.1mol), drip off and be heated to Backflow, reacts 5h.
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 196g White powder isopentenyl gland purine, yield is 96.6%.
(Embodiment 6)
The present embodiment is the synthetic method of 6-benzyl aminopurine, 1.~5. identical, difference the step of the method is with embodiment 1 Be step 6.:By chloro- 1H- pyrazoles [3,4-d] pyrimidines of the 4- of 154.5g(1mol)It is dissolved in 200mL ethanol, first adds 122g Triethylamine(1.2mol), then it is slowly added dropwise the benzylamine of 118g(1.1mol), drip off and be heated to backflow, react 5h.
After reaction terminates, ethanol is evaporated, adds water, be extracted with ethyl acetate 3 times, organic layer is spin-dried for, obtain 216g White needles 6-benzyl aminopurine, yield is 96.0%.
Table 1
Embodiment 1 Embodiment 2 Embodiment 3 Embodiment 4 Embodiment 5 Embodiment 6
Target compound Adenine 6-Furfurylaminopurine Oxyenadenine Carbonyl enadenine Isopentenyl gland purine 6-benzyl aminopurine
Ammoniacal liquor/aminated compounds 138g, concentration are the ammoniacal liquor of 28wt% The 2- furylamines of 107g 4- amino-2-methyls-the 2- of 111g Butenol The 3- methyl-2-butene acyls of 103g Amine 4- amino-2-methyls-the 2- of 93g Butylene The benzylamine of 118g
Target product The adenine of 130g The 6-Furfurylaminopurine of 208g The oxyenadenine of 212g The carbonyl enadenine of 210g The isopentenyl gland purine of 196g The 6-benzyl aminopurine of 216g
Yield 96.3% 96.7% 96.8% 96.8% 96.6% 96.0%

Claims (9)

1. the synthetic method of a kind of adenine and its derivative, it is characterised in that have steps of:
1. 2- tartronic acid diethylesters are obtained by the oxidized reaction of diethyl malonate and dimethyl dioxirane;
2. 2- hydroxyl malonamides are obtained through ammonolysis reaction by 2- tartronic acids diethylester and ammoniacal liquor;
3. 5- hydroxy pyrimidines -4,6- is obtained through ring-closure reaction by 2- hydroxyls malonamide and trimethyl orthoformate(1H,5H)- two Ketone;
4. by 5- hydroxy pyrimidines -4,6-(1H,5H)- diketone obtains 4,5,6- trichloropyrimidines with phosgene through chlorination reaction;
5. chloro- 1H- pyrazoles [3,4-d] pyrimidines of 4- are obtained through ring-closure reaction by 4,5,6- trichloropyrimidines and amitraz hydrochloride;
6. by chloro- 1H- pyrazoles [3,4-d] pyrimidines of 4- and ammoniacal liquor or aminated compounds in the presence of triethyl amine through aminating reaction Obtain adenine or derivatives thereof.
2. the synthetic method of adenine according to claim 1 and its derivative, it is characterised in that:Above-mentioned steps oxygen 1. Change reaction is carried out in the presence of a catalyst;The catalyst is preferably nickel acetate;The consumption of the catalyst is the third two The 0.1%~1% of diethyl phthalate weight.
3. the synthetic method of adenine according to claim 1 and its derivative, it is characterised in that:Above-mentioned steps 1. middle institute It is 1: 1~1: 3, preferably 1: 1.5 that diethyl malonate is stated with the mol ratio of the dimethyl dioxirane.
4. the synthetic method of adenine according to claim 1 and its derivative, it is characterised in that:Above-mentioned steps oxygen 1. Change reaction is carried out in the presence of alcohols solvent;The alcohols solvent is methyl alcohol, ethanol, isopropanol or n-butanol;On Step oxidizing reaction temperature 1. is stated for back flow reaction temperature;Above-mentioned steps oxidation time 1. is 2~10h.
5. according to the described adenine of one of Claims 1-4 and its synthetic method of derivative, it is characterised in that:Above-mentioned step It is rapid 2. described in the mol ratio of 2- tartronic acids diethylester and the ammoniacal liquor be 1: 1~1: 3, preferably 1: 2;Above-mentioned steps are 2. Ammonolysis reaction temperature be 50~150 DEG C, the ammonolysis reaction time be 1~5h.
6. according to the described adenine of one of Claims 1-4 and its synthetic method of derivative, it is characterised in that:Above-mentioned step It is rapid 3. described in the mol ratio of 2- hydroxyls malonamide and the trimethyl orthoformate be 1: 1~1: 3;Above-mentioned steps cyclization 3. Reaction is carried out in the presence of alcohols solvent;The alcohols solvent is methyl alcohol, ethanol, isopropanol or n-butanol.
7. according to the described adenine of one of Claims 1-4 and its synthetic method of derivative, it is characterised in that:Above-mentioned step It is rapid 4. in be passed through the temperature of phosgene be -5~10 DEG C, the time for being passed through phosgene is 1~3h;Above-mentioned steps chlorination reaction 4. be Carried out in the presence of NaOH;Above-mentioned steps chlorination reaction 4. is carried out in dichloroethane solvent.
8. according to the described adenine of one of Claims 1-4 and its synthetic method of derivative, it is characterised in that:Above-mentioned step It is rapid 5. described in the mol ratio of 4,5,6- trichloropyrimidines and the amitraz hydrochloride be 1: 1~1: 3, preferably 1: 1;Above-mentioned steps 5. ring-closure reaction is carried out in the presence of alcohols solvent;The alcohols solvent is methyl alcohol, ethanol, isopropanol or positive fourth Alcohol.
9. according to the described adenine of one of Claims 1-4 and its synthetic method of derivative, it is characterised in that:Above-mentioned step It is rapid 6. described in the mol ratio of chloro- 1H- pyrazoles [3,4-d] pyrimidines of 4- and the ammoniacal liquor or aminated compounds be 1: 1~1: 3; Above-mentioned steps 6. described in the mol ratio of chloro- 1H- pyrazoles [3,4-d] pyrimidines of 4- and the triethylamine be 1: 1~1: 3;Above-mentioned step Rapid aminating reaction 6. is carried out in the presence of alcohols solvent;The alcohols solvent is methyl alcohol, ethanol, isopropanol or just Butanol;Above-mentioned steps aminating reaction temperature 6. is back flow reaction temperature;The above-mentioned steps aminating reaction time 6. is 2~10h.
CN201710108136.8A 2017-02-27 2017-02-27 The synthetic method of adenine and its derivative Active CN106883233B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710108136.8A CN106883233B (en) 2017-02-27 2017-02-27 The synthetic method of adenine and its derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710108136.8A CN106883233B (en) 2017-02-27 2017-02-27 The synthetic method of adenine and its derivative

Publications (2)

Publication Number Publication Date
CN106883233A true CN106883233A (en) 2017-06-23
CN106883233B CN106883233B (en) 2019-02-19

Family

ID=59180003

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710108136.8A Active CN106883233B (en) 2017-02-27 2017-02-27 The synthetic method of adenine and its derivative

Country Status (1)

Country Link
CN (1) CN106883233B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108864099A (en) * 2018-09-08 2018-11-23 湖北荆洪生物科技股份有限公司 A kind of synthetic method of high-purity 6-Furfurylaminopurine
CN110563582A (en) * 2019-10-09 2019-12-13 合肥诚志生物制药有限公司 Process for preparing 2-hydroxy-2-phenyl-malonamide
CN111560019A (en) * 2020-05-11 2020-08-21 安徽京和生物药业科技有限公司 Method for synthesizing isopentenyl adenine or derivatives thereof by one-step method
CN111662293A (en) * 2020-06-23 2020-09-15 成都工业学院 Preparation method of zeatin
CN116535407A (en) * 2023-05-08 2023-08-04 河南省精细化工研究院有限公司 Preparation process of plant endogenous cytokinin enadenine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102887899A (en) * 2012-09-28 2013-01-23 扬州大学 Novel chemical synthesis method for adenine
CN103709164A (en) * 2013-12-04 2014-04-09 浙江工业大学 Synthetic method for adenine
CN105348285A (en) * 2015-12-02 2016-02-24 新发药业有限公司 Low-cost and high-yield adenine preparation method
CN105418613A (en) * 2015-12-02 2016-03-23 新发药业有限公司 Environment-friendly preparation method of adenine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102887899A (en) * 2012-09-28 2013-01-23 扬州大学 Novel chemical synthesis method for adenine
CN103709164A (en) * 2013-12-04 2014-04-09 浙江工业大学 Synthetic method for adenine
CN105348285A (en) * 2015-12-02 2016-02-24 新发药业有限公司 Low-cost and high-yield adenine preparation method
CN105418613A (en) * 2015-12-02 2016-03-23 新发药业有限公司 Environment-friendly preparation method of adenine

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108864099A (en) * 2018-09-08 2018-11-23 湖北荆洪生物科技股份有限公司 A kind of synthetic method of high-purity 6-Furfurylaminopurine
WO2020048343A1 (en) * 2018-09-08 2020-03-12 湖北荆洪生物科技股份有限公司 Synthesis method for 6-furfurylaminopurine
CN110563582A (en) * 2019-10-09 2019-12-13 合肥诚志生物制药有限公司 Process for preparing 2-hydroxy-2-phenyl-malonamide
CN111560019A (en) * 2020-05-11 2020-08-21 安徽京和生物药业科技有限公司 Method for synthesizing isopentenyl adenine or derivatives thereof by one-step method
CN111662293A (en) * 2020-06-23 2020-09-15 成都工业学院 Preparation method of zeatin
CN111662293B (en) * 2020-06-23 2021-10-22 成都工业学院 Preparation method of zeatin
CN116535407A (en) * 2023-05-08 2023-08-04 河南省精细化工研究院有限公司 Preparation process of plant endogenous cytokinin enadenine

Also Published As

Publication number Publication date
CN106883233B (en) 2019-02-19

Similar Documents

Publication Publication Date Title
CN106883233A (en) The synthetic method of adenine and its derivative
Wang et al. Catalytic asymmetric nucleophilic openings of 3-substituted oxetanes
CN104130198B (en) 2-amino-4,6-dimethoxypyridin and preparation method thereof
CN104371966A (en) Gene engineering strain capable of synthesizing phloroglucinol from acetic acid and construction method and application thereof
CN105218537B (en) Berberine benzimidazole compounds or pharmaceutically acceptable salts thereof as well as preparation methods and applications of berberine benzimidazole compounds or pharmaceutically acceptable salts of berberine benzimidazole compounds
CN103772295A (en) Preparation method of Ticagrelor intermediate 4,6-dichloro-2-(mercaptopropionic)-5-aminopyrimidine
CN106316869A (en) Synthesis method of beta-alanine methyl ester salt product
CN103896858B (en) The preparation technology of cytosine
CN105294570B (en) A kind of synthetic method of 3,4 dihydropyrimidinonesands/thioketone
CN111057053B (en) Preparation method of zolpidem
CN102633682B (en) Continuous production process of cyanoacetate
CN109761916A (en) A kind of improvement synthetic method of orotic acid
CN104531797A (en) L-aspartic acid making process
CN106866547B (en) Synthesis method of 2-ethoxy-4, 6-dichloropyrimidine
CN102993131A (en) Method for preparing cyclohexene oxide by cyclization of o-chlorocyclohexanol
CN105601574A (en) Method for preparing 2-amino-4,6-dimethoxy pyrimidine
CN105925312A (en) Method for preparing chlorcosane
CN101928310B (en) 3,2',6'-tri-N-acetyl gentamicin C1aprepn
CN105949133A (en) 2-amino-4,6-dichloro-5-formamide pyrimidine synthesis method
CN112442032A (en) Preparation method of medicine intermediate benzopyrimidinoquinolinone derivative
CN105622515B (en) A kind of synthetic method of 4 (5)-hydroxy methylimidazole
CN105348285A (en) Low-cost and high-yield adenine preparation method
CN104211644B (en) A kind of synthetic method of 3,4-dichloro-pyridazine
CN102952086B (en) Preparation method of 2-morpholinyl-substituted pyrimidine compounds
CN103030640B (en) Preparation method of pemetrexed or pemetrexed salt

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant